Divestment of IVT Industrier AB (SE) to a consortium led by ABN AMRO Capital (NL) — SEK 500 million Industrials Divestment of IVT Industrier AB (SE) to a consortium led by ABN AMRO Capital (NL) — SEK 500 million
Merger of Life Science Department of 6-AP Fund (SE) with Medicon Valley Capital (DK) and Innoventus (SE) — SEK 1.7 billion Healthcare Merger of Life Science Department of 6-AP Fund (SE) with Medicon Valley Capital (DK) and Innoventus (SE) — SEK 1.7 billion
Public offer by Outokumpu (FI) for AvestaPolarit (FI) — EUR 1.1 billion Industrials Public offer by Outokumpu (FI) for AvestaPolarit (FI) — EUR 1.1 billion
Total financing for Outokumpu (FI) — EUR 1.1 billion Industrials Total financing for Outokumpu (FI) — EUR 1.1 billion
Acquisition of Bautas (NO) by Ramirent (FI) — NOK 885 million Business Services Acquisition of Bautas (NO) by Ramirent (FI) — NOK 885 million
Simplified procedure directed to 102,000 shareholders Healthcare Simplified procedure directed to 102,000 shareholders
Debt financing for Ramirent (FI) / Bautas (NO) — EUR 112 million Business Services Debt financing for Ramirent (FI) / Bautas (NO) — EUR 112 million
Pharmacia (US) / Monsanto (US) — Spin-off — USD 3.7 billion Healthcare Pharmacia (US) / Monsanto (US) — Spin-off — USD 3.7 billion
Merger between JOT Automation Oyj (FI) and Elektrobit Oy (FI) — EUR 160 million TMT Merger between JOT Automation Oyj (FI) and Elektrobit Oy (FI) — EUR 160 million
Secondary offering of shares in Nordea (SE) — SEK 4.6 billion FIG Secondary offering of shares in Nordea (SE) — SEK 4.6 billion